Genetic background-dependent thrombotic microangiopathy is related to vascular endothelial growth factor receptor 2 signaling during anti-glomerular basement membrane glomerulonephritis in mice

American Journal of Pathology

Volumn 184, Issue 9, 2014, Pages 2438-2449

  Mesnard, Laurent ^a,b   Cathelin, Dominique ^a,b   Vandermeersch, Sophie ^a,b   Rafat, Cédric ^a,b   Luque, Yosu ^a,b   Sohier, Julie ^a,b   Nochy, Dominique ^c,d   Garcon, Loïc ^c   Callard, Patrice ^c   Jouanneau, Chantal ^a,b   Verpont, Marie Christine ^a,b   Tharaux, Pierre Louis ^d,e   Hertig, Alexandre ^a,b   Rondeau, Eric ^a,b  

^a HÔPITAL TENON   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e PARIS CARDIOVASCULAR RESEARCH CENTER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; RECOMBINANT PROTEIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2; VEGFR2 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; ENDOTHELIUM LESION; FEMALE; FIBRIN DEPOSITION; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENETIC BACKGROUND; GLOMERULONEPHRITIS; GLOMERULUS; HEMOLYTIC ANEMIA; HISTOPATHOLOGY; HYPERTENSION; KIDNEY FAILURE; MICROARRAY ANALYSIS; MOLECULAR GENETICS; MOUSE; MOUSE MODEL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; THROMBOCYTOPENIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; VASCULOTROPIN RECEPTOR 2 GENE; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; DISEASE MODEL; DNA MICROARRAY; ELECTRON MICROSCOPY; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; POLYMERASE CHAIN REACTION; TISSUE MICROARRAY;

ANIMALS; ANTI-GLOMERULAR BASEMENT MEMBRANE DISEASE; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; FLUORESCENT ANTIBODY TECHNIQUE; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; THROMBOTIC MICROANGIOPATHIES; TISSUE ARRAY ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84906235839     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2014.05.020     Document Type: Article

References (49)

1. C. Xie, R. Sharma, H. Wang, X.J. Zhou, and C. Mohan Strain distribution pattern of susceptibility to immune-mediated nephritis J Immunol 172 2004 5047 5055
2. C. Xie, X. Qin, G. Jonnala, Y. Gong, M. Yan, P. Zong, X.J. Zhou, and C. Mohan Enhanced susceptibility to immune nephritis in DBA/1 mice is contingent upon IL-1 expression Clin Immunol 124 2007 49 56
3. C. Xie, Z.S. Rahman, S. Xie, J. Zhu, Y. Du, X. Qin, H. Zhou, X.J. Zhou, and C. Mohan Strain distribution pattern of immune nephritis: a follow-up study Int Immunol 20 2008 719 728
4. X. Montagutelli Effect of the genetic background on the phenotype of mouse mutations J Am Soc Nephrol 11 Suppl 16 2000 S101 S105
5. M. Masugi Uber die spezifischen zytotoxischen Veranderungen der Niere und der Leber durch das spezifische Antiserum (Nephrotoxin and Hepatotoxin): Zugleich ein Beitrag zur Pathogenese der Glomerulonephritis (Specific cytotoxic alterations of kidney and liver induced by specific anti-serum (nephrotoxin and hepatotoxin): a report about the pathogenesis of glomerulonephritis.) German. Jap Path Soc 21 1932 329 341
6. D.J. Salant, and A.V. Cybulsky Experimental glomerulonephritis Methods Enzymol 162 1988 421 461
7. A.M. El Nahas Masugi nephritis: a model for all seasons N. Gretz, Experimental and Genetic Rat Models of Chronic Renal Failure 1993 Karger Basel 49 67
8. P.G. Tipping, and S.R. Holdsworth Cytokines in glomerulonephritis Semin Nephrol 27 2007 275 285
9. P.G. Tipping, and S.R. Holdsworth T cells in crescentic glomerulonephritis J Am Soc Nephrol 17 2006 1253 1263
10. J.R. Timoshanko, and P.G. Tipping Resident kidney cells and their involvement in glomerulonephritis Curr Drug Targets Inflamm Allergy 4 2005 353 362
11. P.G. Tipping, and J. Timoshanko Contributions of intrinsic renal cells to crescentic glomerulonephritis Nephron Exp Nephrol 101 2005 e173 e178
12. C.C. Linder Genetic variables that influence phenotype ILAR J 47 2006 132 140
13. E.M. Simpson, C.C. Linder, E.E. Sargent, M.T. Davisson, L.E. Mobraaten, and J.J. Sharp Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice Nat Genet 16 1997 19 27
14. R.A. Taft, M. Davisson, and M.V. Wiles Know thy mouse Trends Genet 22 2006 649 653
15. C.C. Linder The influence of genetic background on spontaneous and genetically engineered mouse models of complex diseases Lab Anim (NY) 30 2001 34 39
16. L. Mesnard, A.C. Keller, M.L. Michel, S. Vandermeersch, C. Rafat, E. Letavernier, Y. Tillet, E. Rondeau, and M.C. Leite-de-Moraes Invariant natural killer T cells and TGF-beta attenuate anti-GBM glomerulonephritis J Am Soc Nephrol 20 2009 1282 1292
17. A. Hertig, J. Berrou, Y. Allory, L. Breton, F. Commo, M.A. Costa De Beauregard, P. Carmeliet, and E. Rondeau Type 1 plasminogen activator inhibitor deficiency aggravates the course of experimental glomerulonephritis through overactivation of transforming growth factor beta FASEB J 17 2003 1904 1906
18. W.H. Zhu, M. Iurlaro, A. MacIntyre, E. Fogel, and R.F. Nicosia The mouse aorta model: influence of genetic background and aging on bFGF- and VEGF-induced angiogenic sprouting Angiogenesis 6 2003 193 199
19. A.R. Morley, and J. Wheeler Cell proliferation within Bowman's capsule in mice J Pathol 145 1985 315 327
20. L. Mesnard, C. Rafat, S. Vandermeersch, A. Hertig, D. Cathelin, Y.C. Xu-Dubois, C. Jouanneau, A.C. Keller, J.A. Ribeil, M.C. Leite-de-Moraes, and E. Rondeau Vitronectin dictates intraglomerular fibrinolysis in immune-mediated glomerulonephritis FASEB J 25 2011 3543 3553
21. D. Schiwek, N. Endlich, L. Holzman, H. Holthöfer, W. Kriz, and K. Endlich Stable expression of nephrin and localization to cell-cell contacts in novel murine podocyte cell lines Kidney Int 66 2004 91 101
22. G. Bollee, M. Flamant, S. Schordan, C. Fligny, E. Rumpel, M. Milon, E. Schordan, N. Sabaa, S. Vandermeersch, A. Galaup, A. Rodenas, I. Casal, S.W. Sunnarborg, D.J. Salant, J.B. Kopp, D.W. Threadgill, S.E. Quaggin, J.C. Dussaule, S. Germain, L. Mesnard, K. Endlich, C. Boucheix, X. Belenfant, P. Callard, N. Endlich, and P.L. Tharaux Epidermal growth factor receptor promotes glomerular injury and renal failure in rapidly progressive crescentic glomerulonephritis Nat Med 17 2011 1521
23. C.F. Schaefer, K. Anthony, S. Krupa, J. Buchoff, M. Day, T. Hannay, and K.H. Buetow PID: the Pathway Interaction Database Nucleic Acids Res 37 2009 D674 D679
24. E.S. Rennel, M.A. Hamdollah-Zadeh, E.R. Wheatley, A. Magnussen, Y. Schuler, S.P. Kelly, C. Finucane, D. Ellison, S. Cebe-Suarez, K. Ballmer-Hofer, S. Mather, L. Stewart, D.O. Bates, and S.J. Harper Recombinant human VEGF165b protein is an effective anti-cancer agent in mice Eur J Cancer 44 2008 1883 1894
25. S. Ran, X. Huang, A. Downes, and P.E. Thorpe Evaluation of novel antimouse VEGFR2 antibodies as potential antiangiogenic or vascular targeting agents for tumor therapy Neoplasia 5 2003 297 307
26. D. Yuen, B. Pytowski, and L. Chen Combined blockade of VEGFR-2 and VEGFR-3 inhibits inflammatory lymphangiogenesis in early and middle stages Invest Ophthalmol Vis Sci 52 2011 2593 2597
27. A. Hertig, and E. Rondeau Role of the coagulation/fibrinolysis system in fibrin-associated glomerular injury J Am Soc Nephrol 15 2004 844 853
28. W.G. Couser Basic and translational concepts of immune-mediated glomerular diseases J Am Soc Nephrol 23 2012 381 399
29. N.L. Ward, E. Moore, K. Noon, N. Spassil, E. Keenan, T.L. Ivanco, and J.C. LaManna Cerebral angiogenic factors, angiogenesis, and physiological response to chronic hypoxia differ among four commonly used mouse strains J Appl Physiol 102 2007 1927 1935
30. G.J. Downing, and J.F. Battey Jr. Technical assessment of the first 20 years of research using mouse embryonic stem cell lines Stem Cells 22 2004 1168 1180
31. M.S. Rogers, R.M. Rohan, A.E. Birsner, and R.J. D'Amato Genetic loci that control vascular endothelial growth factor-induced angiogenesis FASEB J 17 2003 2112 2114
32. S.M. Marques, P.P. Campos, P.R. Castro, C.C. Cardoso, M.A. Ferreira, and S.P. Andrade Genetic background determines mouse strain differences in inflammatory angiogenesis Microvasc Res 82 2011 246 252
33. C.K. Chan, L.N. Pham, C. Chinn, C. Spee, S.J. Ryan, R.J. Akhurst, and D.R. Hinton Mouse strain-dependent heterogeneity of resting limbal vasculature Invest Ophthalmol Vis Sci 45 2004 441 447
34. Z.G. Laszik, and F.G. Silva Hemolytic uremic syndrome, thrombotic thrombocytopenic purpura, and other thrombotic microangiopathies J.C. Jennette, J.L. Olson, M.M. Schwartz, F.G. Silva, Heptinstall's Pathology of the Kidney ed 6. 2007 Lippincott Williams & Wilkins Philadelphia 676 684
35. G. Bollee, N. Patey, G. Cazajous, C. Robert, J.M. Goujon, F. Fakhouri, P. Bruneval, L.H. Noel, and B. Knebelmann Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib Nephrol Dial Transplant 24 2009 682 685
36. D. Nochy, C. Lefaucheur, and G. Hill VEGF inhibition and renal thrombotic microangiopathy N Engl J Med 359 2008 206 author reply -7
37. C. Frangie, C. Lefaucheur, J. Medioni, C. Jacquot, G.S. Hill, and D. Nochy Renal thrombotic microangiopathy caused by anti-VEGF-antibody treatment for metastatic renal-cell carcinoma Lancet Oncol 8 2007 177 178
38. Y. Masuda, A. Shimizu, T. Mori, T. Ishiwata, H. Kitamura, R. Ohashi, M. Ishizaki, G. Asano, Y. Sugisaki, and N. Yamanaka Vascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis Am J Pathol 159 2001 599 608
39. B. Hohenstein, M. Colin, C. Foellmer, K.U. Amann, R.A. Brekken, C. Daniel, and C.P. Hugo Autocrine VEGF-VEGF-R loop on podocytes during glomerulonephritis in humans Nephrol Dial Transplant 25 2010 3170 3180
40. G.M. Stave, and B.P. Croker Thrombotic microangiopathy in anti-glomerular basement membrane glomerulonephritis Arch Pathol Lab Med 108 1984 747 751
41. H. Bazari, A.R. Guimaraes, and Y.B. Kushner Case records of the Massachusetts General Hospital: case 20-2012: a 77-year-old man with leg edema, hematuria, and acute renal failure N Engl J Med 366 2012 2503 2515
42. J. Bariety, C. Mandet, G.S. Hill, and P. Bruneval Parietal podocytes in normal human glomeruli J Am Soc Nephrol 17 2006 2770 2780
43. P.S. Thorner, M. Ho, V. Eremina, Y. Sado, and S. Quaggin Podocytes contribute to the formation of glomerular crescents J Am Soc Nephrol 19 2008 495 502
44. M.J. Moeller, A. Soofi, I. Hartmann, M. Le Hir, R. Wiggins, W. Kriz, and L.B. Holzman Podocytes populate cellular crescents in a murine model of inflammatory glomerulonephritis J Am Soc Nephrol 15 2004 61 67
45. V. Eremina, J.A. Jefferson, J. Kowalewska, H. Hochster, M. Haas, J. Weisstuch, C. Richardson, J.B. Kopp, M.G. Kabir, P.H. Backx, H.P. Gerber, N. Ferrara, L. Barisoni, C.E. Alpers, and S.E. Quaggin VEGF inhibition and renal thrombotic microangiopathy N Engl J Med 358 2008 1129 1136
46. V. Eremina, H.J. Baelde, and S.E. Quaggin Role of the VEGF-a signaling pathway in the glomerulus: evidence for crosstalk between components of the glomerular filtration barrier Nephron Physiol 106 2007 p32 p37
47. J. Ratelade, T.A. Lavin, A.O. Muda, L. Morisset, G. Mollet, O. Boyer, D.S. Chen, A. Henger, M. Kretzler, N. Hubner, C. Thery, M.C. Gubler, X. Montagutelli, C. Antignac, and E.L. Esquivel Maternal environment interacts with modifier genes to influence progression of nephrotic syndrome J Am Soc Nephrol 19 2008 1491 1499
48. G. Mollet, J. Ratelade, O. Boyer, A.O. Muda, L. Morisset, T.A. Lavin, D. Kitzis, M.J. Dallman, L. Bugeon, N. Hubner, M.C. Gubler, C. Antignac, and E.L. Esquivel Podocin inactivation in mature kidneys causes focal segmental glomerulosclerosis and nephrotic syndrome J Am Soc Nephrol 20 2009 2181 2189
49. K. Sison, V. Eremina, H. Baelde, W. Min, M. Hirashima, I.G. Fantus, and S.E. Quaggin Glomerular structure and function require paracrine, not autocrine, VEGF-VEGFR-2 signaling J Am Soc Nephrol 21 2010 1691 1701